Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Northwest Biothrputcs Inc (NWBO)

Northwest Biothrputcs Inc (NWBO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Northwest Biotherapeutics Presents Updated Survival Data from Phase III Trial of DCVax®-L For Glioblastoma Using Individual Patient Level Data in Multiple Independent Analyses PR Newswire - Wed Jul 8, 1:24PM CDT

Scientific Presentation at British Neuro-Oncology Annual Meeting Shows Original Analysis of   Survival Extension Was Likely Underestimated

NWBO : 0.1717 (+1.54%)
Northwest Biotherapeutics Announces Scientific Presentation on Propensity Score Matching at the British Neuro-Oncology Society Annual Meeting PR Newswire - Thu Jul 2, 1:17PM CDT

BETHESDA, Md. , July 2, 2026 /PRNewswire/ -- Northwest Biotherapeutics (OTCQB:NWBO) (the "Company" or "NWBio"), a biotechnology company developing DCVax® personalized immune therapies for solid...

NWBO : 0.1717 (+1.54%)
Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform PR Newswire - Thu Apr 30, 11:30AM CDT

BETHESDA, Md. , April 30, 2026 /PRNewswire/ -- Northwest Biotherapeutics, Inc. (OTCQB:NWBO) (the "Company" or "NWBio"), a biotechnology company developing DCVax® personalized immune therapies for...

NWBO : 0.1717 (+1.54%)
Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic PR Newswire - Tue Apr 21, 8:30AM CDT

BETHESDA, Md. , April 21, 2026 /PRNewswire/ -- Northwest Biotherapeutics, Inc. (OTCQB:NWBO) (the "Company" or "NWBio"), a biotechnology company developing DCVax® personalized immune therapies for...

NWBO : 0.1717 (+1.54%)
Northwest Biotherapeutics Announces That Construction Activities Are Under Way For the First Grade C Manufacturing Suite in the Sawston, UK Facility PR Newswire - Thu Nov 20, 2025

BETHESDA, Md. , Nov. 20, 2025 /PRNewswire/ -- Northwest Biotherapeutics (OTCQB:NWBO) (the "Company" or "NWBio"), a biotechnology company developing DCVax® personalized immune therapies for solid...

NWBO : 0.1717 (+1.54%)
Northwest Biotherapeutics Announces That Its Acquisition of Advent BioServices Ltd. Has Closed PR Newswire - Fri Oct 24, 2025

BETHESDA, Md. , Oct. 24, 2025 /PRNewswire/ -- Northwest Biotherapeutics, Inc. (OTCQB:NWBO) (the "Company" or "NWBio"), a biotechnology company developing DCVax® personalized immune therapies for...

NWBO : 0.1717 (+1.54%)
Northwest Biotherapeutics Settles Litigation Over Option Awards Tipranks - Wed Oct 15, 2025

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Northwest...

NWBO : 0.1717 (+1.54%)
Northwest Biotherapeutics Announces Agreement to Acquire Advent BioServices Ltd. PR Newswire - Wed Aug 27, 2025

BETHESDA, Md. , Aug. 27, 2025 /PRNewswire/ -- Northwest Biotherapeutics, Inc. (OTCQB:NWBO) (the "Company" or "NWBio"), a biotechnology company developing DCVax® personalized immune therapies...

NWBO : 0.1717 (+1.54%)
Northwest Biotherapeutics Announces the Passing of Its Senior Vice President and General Counsel, Mr. Les Goldman PR Newswire - Mon Aug 18, 2025

BETHESDA, Md. , Aug. 18, 2025 /PRNewswire/ -- Northwest Biotherapeutics (OTCQB:NWBO) (the "Company" or "NW Bio"), a biotechnology company developing DCVax® personalized immune therapies...

NWBO : 0.1717 (+1.54%)
Investors Watching Two Small-Caps for News on Potential Major Advancements in Cancer Treatments Yolowire - Mon Jan 13, 2025

Both %ShuttlePharmaceuticals (Nasdaq: $SHPH) and %NorthwestBiotherapeutics (OTC: $NWBO) are companies that have attracted investor attention due to their promising %Cancer treatments. Both have relatively...

NWBO : 0.1717 (+1.54%)
MRK : 131.07 (+0.45%)
SHPH : 2.89 (-3.34%)
BMY : 62.09 (+0.94%)

Barchart Exclusives

Tesla Missed by 38% But Elon Musk Is Not Worried. Here’s What TSLA Investors Should Make of That. Barchart - Sun Jul 26, 4:38PM CDT
Tesla posted mixed Q2 results, but CEO Elon Musk assured investors of incredible returns following heavy capex. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.